IQVIA Receives WCG Pinnacle Award for Excellence in Site Relationships

RESEARCH TRIANGLE PARK, N.C.--(BUSINESS WIRE)--IQVIA (NYSE:IQV), a leading global provider of clinical research services, commercial insights and healthcare intelligence to the life sciences and healthcare industries, has been honored with the WCG Pinnacle Award for Site Relationships in Professionalism and Communication. The award recognizes IQVIA’s commitment to building strong, collaborative partnerships with clinical trial sites worldwide.

The award is based on feedback from over 12,000 participants in WCG’s 2025 CenterWatch Global Site Relationship Survey, which evaluated organizations on protocol design, site management, operational efficiency, participant diversity and use of technology.

“This award reflects the trust and collaboration we’ve built with our site partners,” said Brian O’Dwyer, president, Global Clinical Development at IQVIA. “At IQVIA, we believe that operational excellence begins with human connection — clear communication, mutual respect and shared purpose. We’re honored to be recognized by the investigators we work with for our professionalism and communication excellence. It is collaboration and partnership with our sites that drives better outcomes for patients and accelerates the future of clinical research.”

IQVIA continues to set industry standards through innovation, operational excellence and a deep focus on strong collaborative relationships in clinical research.

About IQVIA

IQVIA (NYSE:IQV) is a leading global provider of clinical research services, commercial insights and healthcare intelligence to the life sciences and healthcare industries. IQVIA’s portfolio of solutions are powered by IQVIA Connected Intelligence™ to deliver actionable insights and services built on high-quality health data, Healthcare-grade AI^®, advanced analytics, the latest technologies and extensive domain expertise. IQVIA is committed to using AI responsibly, with AI-powered capabilities built on best-in-class approaches to privacy, regulatory compliance and patient safety, and delivering AI to the high standards of trust, scalability and precision demanded by the industry. With approximately 90,000 employees in over 100 countries, including experts in healthcare, life sciences, data science, technology and operational excellence, IQVIA is dedicated to accelerating the development and commercialization of innovative medical treatments to help improve patient outcomes and population health worldwide.

IQVIA is a global leader in protecting individual patient privacy. The company uses a wide variety of privacy-enhancing technologies and safeguards to protect individual privacy while generating and analyzing information on a scale that helps healthcare stakeholders identify disease patterns and correlate with the precise treatment path and therapy needed for better outcomes. IQVIA’s insights and execution capabilities help biotech, medical device and pharmaceutical companies, medical researchers, government agencies, payers and other healthcare stakeholders tap into a deeper understanding of diseases, human behaviors and scientific advances, in an effort to advance their path toward cures. To learn more, visit www.iqvia.com.

IQVIAFIN